Zhao Xiao-ling, Chen Wei-qiang, Li Jing-mei, Zhang Su-juan, Tian Lu-fang, Wang Liang, Gong Jing-bo, Yang Zhi-hua
Institute of Health and Enviramental Medicine, Academy of Military Medical Sceience, Tianjin, China.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Feb;25(2):145-9.
To prepare distinct human McAbs to TNF-alpha with high neutralizing potency using ribosome display technology.
The immunoglobulin heavy and light chain variable (VH, VL) genes were prepared from the peripheral blood lymphocytes in three arthritis patients by PCR. The genes encoding VH/K fragments were prepared by randomly combining VH and VL genes by SOE PCR. TNF-alpha binding fragments were selected over three cycles of ribosome display and the selected VH/Ks genes were cloned into pET22b(+)/BL21(DE3), from which soluble VH/K fragments were prepared. The expressed products of selected clones were analyzed by ELISA. Then the positive clones were characterized.
A human VH/K gene library with 6.7x10(12) numbers used for ribosome display was constructed. Among the 180 selected clones, two clones TRB21 and TRB409 exhibiting the highest ELISA signals were isolated. The analysis of the sequence of TRB21 and TRB409 showed that they were new human immunoglobulin V genes to TNF-alpha and they recognize TNF-alpha specifically and antagonize the cytolytic effect of TNF-alpha on 1929 cell.
The selected VH/Ks to TNF-alpha will be useful for constructing engineering antibodies with high affinity against arthritis. Ribosome display is a rapid means of generating fully human antibody fragments in vitro.
利用核糖体展示技术制备具有高中和活性的抗人肿瘤坏死因子-α(TNF-α)单克隆抗体(McAbs)。
采用聚合酶链反应(PCR)从3例关节炎患者外周血淋巴细胞中获取免疫球蛋白重链和轻链可变区(VH、VL)基因。通过重叠延伸PCR(SOE PCR)随机组合VH和VL基因,制备编码VH/K片段的基因。经三轮核糖体展示筛选TNF-α结合片段,将筛选出的VH/Ks基因克隆至pET22b(+)/BL21(DE3)中,制备可溶性VH/K片段。采用酶联免疫吸附测定(ELISA)分析筛选克隆的表达产物,随后对阳性克隆进行鉴定。
构建了库容为6.7×10(12) 用于核糖体展示的人VH/K基因文库。在180个筛选克隆中,分离出两个ELISA信号最强的克隆TRB21和TRB409。TRB21和TRB409序列分析表明,它们是新型抗TNF-α人免疫球蛋白V基因,能特异性识别TNF-α并拮抗TNF-α对1929细胞的细胞溶解作用。
筛选出的抗TNF-α VH/Ks对构建高亲和力抗关节炎工程抗体具有重要意义。核糖体展示是一种在体外快速产生完全人源抗体片段的方法。